Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shertech Pharmacy is a specialized nuclear pharmacy provider that focuses on the compounding and distribution of radiopharmaceuticals for diagnostic and therapeutic applications. Founded in North Carolina, the company operates a network of specialized pharmacies that prepare patient-specific doses of radioactive drugs used in medical imaging and treatment. In 2017, Shertech was acquired by Jubilant Pharma, a global integrated pharmaceutical company, to expand its radiopharmaceutical distribution footprint in the United States. Today, it operates as part of the Jubilant Radiopharma business, serving hospitals and clinics across the Southeastern United States. Its services are critical for oncology, cardiology, and neurology departments requiring precise, time-sensitive radioactive tracers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shertech Pharmacy.